Home/Publication/Qiming Joins Apricot Capital in RNA Drug Delivery
Qiming Joins Apricot Capital in RNA Drug Delivery 

21 Aug 2025

US$ 20.00

Qiming Venture Partners has participated in the seed financing round of Vivatides Therapeutics that raised tens of ......

Price / article: US$20.00
OR existing subscriber
Related Publications

BAI Capital, alongside other existing investors of Looki, have made a follow-on investment in the consumer ......

Temasek Holdings (Pte) Ltd (Temasek) could re-organise its corporate structure to shore up its investment returns and...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.